These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 6225760

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Clinical evaluation of ceftazidime in internal medicine in Japan.
    Shimada K.
    J Antimicrob Chemother; 1983 Jul; 12 Suppl A():395-7. PubMed ID: 6225765
    [Abstract] [Full Text] [Related]

  • 3. Ceftazidime in clinical practice.
    Alestig K, Eilard T, Norrby R, Svensson R, Trollfors B, Brorson JE.
    J Antimicrob Chemother; 1983 Jul; 12 Suppl A():111-4. PubMed ID: 6225759
    [Abstract] [Full Text] [Related]

  • 4. Ceftazidime in severe infections: a Swiss multicentre study.
    Francioli P, Clément M, Geroulanos S, von Graevenitz A, Luthy R, Regamey C, Stalder H, Vogt M, Waldvogel FA.
    J Antimicrob Chemother; 1983 Jul; 12 Suppl A():139-46. PubMed ID: 6225761
    [Abstract] [Full Text] [Related]

  • 5. Clinical experience with ceftazidime in urology in Japan.
    Kawamura N.
    J Antimicrob Chemother; 1983 Jul; 12 Suppl A():65-70. PubMed ID: 6352657
    [Abstract] [Full Text] [Related]

  • 6. Ceftazidime--a new extended-spectrum cephalosporin.
    Gozzard DI, Geddes AM, Farrell ID, Eykyn SJ, Phillips I, Wise R, Brown RM.
    Lancet; 1982 May 22; 1(8282):1152-6. PubMed ID: 6122940
    [Abstract] [Full Text] [Related]

  • 7. Ceftazidime treatment in intensive care patients.
    van Dalen R, Muytjens HL, Gimbrère JS.
    J Antimicrob Chemother; 1983 Jul 22; 12 Suppl A():189-97. PubMed ID: 6225763
    [Abstract] [Full Text] [Related]

  • 8. The evaluation of ceftazidime in the treatment of bacterial infections in eighty seriously ill patients.
    Walstad RA, Hellum KB, Svarva PL, Ingram PM.
    J Antimicrob Chemother; 1983 Jul 22; 12 Suppl A():131-7. PubMed ID: 6352614
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Ceftazidime therapy for serious infections.
    Bint AJ, Constable J, Patton KR, Constable FL.
    J Antimicrob Chemother; 1983 Jul 22; 12 Suppl A():115-21. PubMed ID: 6352613
    [Abstract] [Full Text] [Related]

  • 11. Clinical evaluation of cefazedone.
    Koch E, Friese J, Debuch KE.
    Arzneimittelforschung; 1979 Jul 22; 29(2a):456-60. PubMed ID: 582726
    [Abstract] [Full Text] [Related]

  • 12. [Clinical evaluation of ceftazidime in the field of pediatrics].
    Koshinami M, Watanabe A.
    Jpn J Antibiot; 1984 Mar 22; 37(3):344-8. PubMed ID: 6376847
    [Abstract] [Full Text] [Related]

  • 13. The new beta-lactamase-stable cephalosporins.
    Neu HC.
    Ann Intern Med; 1982 Sep 22; 97(3):408-19. PubMed ID: 6810737
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Ceftazidime in the therapy of serious Gram-negative bacillary infections.
    Pottage JC, Karakusis PH, Fliegelman RM, Levin S, Trenholme GM.
    J Antimicrob Chemother; 1983 Jul 22; 12 Suppl A():223-8. PubMed ID: 6352623
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.